Psychedelics may improve psychotherapy outcomes, but obstacles remain

Psychedelics as an adjunctive therapy to psychiatric counseling may be feasible for anxiety and mood disorders, but proper blinding in future clinical trials presents an ongoing obstacle to wider acceptance, according to a speaker.“I am not in favor of widespread availability of psychedelics,” Charles B. Nemeroff, MD, PhD, chair of the department of psychiatry and behavioral sciences